期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
局部热消融在NSCLC中的临床应用现状与挑战 被引量:4
1
作者 苟庆 周泽健 +2 位作者 赵明芳 陈晓明 周清 《中国肺癌杂志》 CAS CSCD 北大核心 2020年第2期111-117,共7页
非小细胞肺癌(non-small cell lung cancer, NSCLC)是原发性肺癌的主要类型,手术切除、放化疗、靶向治疗及免疫治疗等是其主要的治疗模式。近年来,热消融在各期NSCLC的临床应用中受到越来越多的关注。热消融作为一种安全、高效的局部治... 非小细胞肺癌(non-small cell lung cancer, NSCLC)是原发性肺癌的主要类型,手术切除、放化疗、靶向治疗及免疫治疗等是其主要的治疗模式。近年来,热消融在各期NSCLC的临床应用中受到越来越多的关注。热消融作为一种安全、高效的局部治疗手段,合理的临床应用可以给NSCLC患者带来更多的临床获益。然而其在NSCLC中的应用仍然存在许多尚待研究探讨的问题。本文对近年来热消融在NSCLC中的应用现状作以综述,旨在探讨目前存在的争议问题和未来研究方向。 展开更多
关键词 肺肿瘤 热消融 局部治疗
暂未订购
Chinese expert consensus on the diagnosis and treatment of bone metastasis in lung cancer(2022 edition) 被引量:1
2
作者 Jianchun Duan Wenfeng Fang +32 位作者 Hairong Xu Jinliang Wang Yuan Chen Yi Ding Xiaorong Dong Yun Fan Beili Gao Jie Hu Yan Huang Cheng Huang Dingzhi Huang Wenhua Liang Lizhu Lin Hui Liu Zhiyong Ma Meiqi Shi Yong Song Chuanhao Tang Jialei Wang Lifeng Wang Yongfeng Wang Zhehai Wang Nong Yang Yu Yao Yan Yu Qitao Yu Hongmei Zhang Jun zhao mingfang zhao Zhengfei Zhu Xiaohui Niu Li Zhang Jie Wang 《Journal of the National Cancer Center》 2023年第4期256-265,共10页
Lung cancer is the leading cause of cancer-related deaths worldwide.Bone is a common metastatic site of lung cancer,about 50%of bone metastatic patients will experience skeletal related events(SREs).SREs not only seri... Lung cancer is the leading cause of cancer-related deaths worldwide.Bone is a common metastatic site of lung cancer,about 50%of bone metastatic patients will experience skeletal related events(SREs).SREs not only seriously impact the quality of life of patients,but also shorten their survival time.The treatment of bone metastasis requires multi-disciplinary therapy(MDT)and development of individualized treatment plan.In order to standardize the diagnosis and treatment of bone metastasis in lung cancer,the expert group of the MDT Committee of the Chinese Medical Doctor Association has developed the expert consensus on the diagnosis and treatment of lung cancer bone metastasis. 展开更多
关键词 Lung cancer Bone metastasis Multi-disciplinary therapy Bone-modifying drugs
暂未订购
Effects of Sodium Nitroprussiate on the Metabolites and Key Enzyme Activities of Carbon-nitrogen Metabolism from Seed Germination to Seedling Period of Cherry Tomato
3
作者 Yongfu ZHANG Lihong GUO +3 位作者 Shuping JIANG Song JIN Liyuan YAO mingfang zhao 《Agricultural Biotechnology》 CAS 2018年第1期20-25,29,共7页
This study was conducted to elucidate the regulating mechanism of sodium nitroprussiate on seed germination and seedling growth of cherry tomato. After the treatment with different concentrations of sodium nitroprussi... This study was conducted to elucidate the regulating mechanism of sodium nitroprussiate on seed germination and seedling growth of cherry tomato. After the treatment with different concentrations of sodium nitroprusside, the effects on the metabolites and key enzyme activities in carbon-nitrogen metabolism of cherry tomato cuhivar Zhuyun as an experimental material were investigated. The results showed that from seed germination to seedling period, the contents of starch and total nitrogen decreased, but the contents of soluble sugar, reducing sugar, sucrose and soluble protein increased firstly and then decreased; and free amino acids content increased gradually. Sodium nitroprusside made the contents of starch, sucrose and free amino acids higher than CK. From seed germination to seedling period in cherry tomato, the activities of amylase, glutamine synthetase (GS) and sucrose phosphate synthase (SPS) decreased; the activities of nitrate reductase (NR) and glutamate synthase (GOGAT) increased at first and decreased then; and the CK and the 0.25 mmol/L sodium nitroprusside treatments exhibited de- creased sucrose synthase (SS) activity, and the trend was increasing at first and decreasing then after the treatment with 0.50 and 1.00 mmol/L sodium nitroprus- side. Sodium nitroprusside treatment improved amylase activity; and the carbon-nitrogen ratio of the CK increased at first and decreased then, while the values of other treatments tended to decrease. In addition, sodium nitroprusside did not affect seed germination potential and germination rate, but significantly improved biomass accumulation, root length and height of seedlings. These data suggest that sodium nitroprusside could affect the conversion of starch and sugar accumulation, delay the decomposition of total nitrogen and soluble protein, and achieve the effects of accelerating the accumulation of free amino acids, and promoting seed germination and seedling growth, and 0.50 mmol/L sodium nitroprusside has the best effect. 展开更多
关键词 Cherry tomatoes Sodium nitroprusside Seed germination SEEDLING Carbon and nitrogen metabolism Key enzymes
在线阅读 下载PDF
Efficacy and safety of IBI351(fulzerasib)monotherapy in KRAS^(G12C) inhibitor-naïve Chinese patients with KRAS^(G12C)-mutated metastatic colorectal cancer:a pooled analysis from phase Ⅰ part of two studies 被引量:1
4
作者 Ying Yuan Yanhong Deng +24 位作者 Yongdong Jin Zengqing Guo Yueyin Pan Cunji Wang Zhiwu Wang Yi Hu Dong Hua Xiangjiao Meng Zhiye Zhang mingfang zhao Xiaorong Dong Dingzhi Huang Xiaoyan Li Lian Liu Meili Sun Huijuan Wang Xiuwen Wang Nong Yang Mingjun Zhang Sheng Hu Dongde Wu Jingjing Huang Sujie Zhang Mengna Huang Kefeng Ding 《Signal Transduction and Targeted Therapy》 2025年第8期4723-4731,共9页
IBI351(also known as fulzerasib or GFH925),an irreversible covalent inhibitor of KRAS^(G12C),has demonstrated promising anti-tumour activity in patients with solid tumours.In this study,data were pooled from the phase... IBI351(also known as fulzerasib or GFH925),an irreversible covalent inhibitor of KRAS^(G12C),has demonstrated promising anti-tumour activity in patients with solid tumours.In this study,data were pooled from the phase I part of two clinical studies(NCT05005234 and NCT05497336),aiming to evaluate the efficacy and safety of IBI351 monotherapy in KRAS^(G12C)inhibitor-naïve Chinese patients with KRAS^(G12C)-mutated metastatic colorectal cancer(CRC).The objective response rate(ORR)was the primary endpoint.Secondary endpoints included disease control rate(DCR),progression-free survival(PFS),and overall survival(OS).As of December 13,2023,56 patients treated with IBI351 monotherapy were included. 展开更多
关键词 fulzerasib solid tumoursin IBIS inhibitor naive irreversible covalent inhibitor
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部